A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods.

– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – “Today's approval reflects ...

With omalizumab recently approved to treat multiple food allergies, allergist-immunologists advised PCPs on how they can use the drug in practice.

In the study, 168 adults and children with peanut allergies and allergies to at least two other common food allergens were given either Xolair injections or a placebo for between 16 and 20 weeks.

Before starting self-injection with Xolair prefilled syringe, the patient must have no prior history of anaphylaxis and be closely observed by a healthcare provider for at least three injections ...

After four months of monthly or bimonthly omalizumab injections, two-thirds of the 118 participants receiving the drug safely ate small quantities of their allergy-triggering foods.

Receiving Xolair Xolair should be given by a healthcare provider in a healthcare setting. Xolair is given in 1 or more injections under the skin (subcutaneous), 1 time every 2 or 4 weeks.

The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe persistent allergic asthma, nasal polyps or chronic idiopathic urticaria, according to ...

Xolair is a prescription biologic medicine that is given as an injection under the skin (subcutaneous). It is the only FDA-approved antibody designed to target and block IgE — an underlying ...

A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies and are accidentally exposed to those foods.

– Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatment – ...

A new study finds that the asthma medication Xolair may substantially reduce severe allergic reactions in people who have multiple food allergies.